Specifically, gain-of-function as well as loss-of-function studies have shown that increased CUX1 activity significantly enhanced cell sensitivity and cancer tissue response to chemotherapy drugs and resulted in increased apoptosis and growth inhibition. The gene discussed is CUX1; the disease is cancer.